Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage

Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage

Bibliographic Details
Main Authors:	Barbara Milani, Tanila Wood dos Santos, Maria Eduarda Souza Guerra, Sheila Oliveira, Cibelly Goulart, Greiciely O. André, Luciana C. C. Leite, Thiago R Converso, Michelle Darrieux
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721071/?tool=EBI

Similar Items

Pneumococcal surface protein A (PspA) prevents killing of Streptococcus pneumoniae by indolicidin
by: Natalha T. Waz, et al.
Published: (2024-10-01)

Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice
by: Monalisa Martins Trentini, et al.
Published: (2024-01-01)

Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments
by: Jingcai Lu, et al.
Published: (2019-02-01)

Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen
by: Philippe Hermand, et al.
Published: (2017-01-01)

A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia.
by: Tanila Wood Dos Santos, et al.
Published: (2022-01-01)

A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia
by: Tanila Wood dos Santos, et al.
Published: (2022-01-01)

Detection of pspA Gene (Pneumococcal Surface Protein A) in Streptococcus pneumoniae Isolated from COVID-19 Patients
by: Afrah Adnan Hashim, et al.
Published: (2023-01-01)

Evidence for a second regulatory binding site on PspF that is occupied by the C-terminal domain of PspA.
by: Eyleen Sabine Heidrich, et al.
Published: (2018-01-01)

PspA-mediated aggregation protects Streptococcus pneumoniae against desiccation on fomites
by: Jessica R. Lane, et al.
Published: (2023-12-01)

An immunoinformatics approach to epitope-based vaccine design against PspA in Streptococcus pneumoniae
by: Lincon Mazumder, et al.
Published: (2023-05-01)

The Yin and Yang of Pneumolysin During Pneumococcal Infection
by: Joana M. Pereira, et al.
Published: (2022-04-01)

Oligopeptide Transporters of Nonencapsulated Streptococcus pneumoniae Regulate CbpAC and PspA Expression and Reduce Complement-Mediated Clearance
by: Courtney D. Thompson, et al.
Published: (2023-02-01)

Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci
by: Chieko Yokota, et al.
Published: (2023-11-01)

A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach
by: Mona Shafaghi, et al.
Published: (2023-11-01)

Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest
by: Kwang, Jimmy, et al.
Published: (2017)

Impact of Endogenous Pneumococcal Hydrogen Peroxide on the Activity and Release of Pneumolysin
by: Jasmin Bazant, et al.
Published: (2023-09-01)

Influence of the mRNA initial region on protein production: a case study using recombinant detoxified pneumolysin as a model
by: Filipe Fusco, et al.
Published: (2024-01-01)

Neuronal death in pneumococcal meningitis is triggered by pneumolysin and RrgA interactions with β-actin.
by: Mahebali Tabusi, et al.
Published: (2021-03-01)

Glycyrrhetinic acid reduces lung inflammation caused by pneumococcal infection by reducing the toxicity of pneumolysin
by: Yan Xu, et al.
Published: (2024-10-01)

Pneumolysin contributes to dysfunction of nasal epithelial barrier for promotion of pneumococcal dissemination into brain tissue
by: Yuki Takahara, et al.
Published: (2024-10-01)

Pneumococcal sialidase promotes bacterial survival by fine-tuning of pneumolysin-mediated membrane disruption
by: Sayaka Shizukuishi, et al.
Published: (2024-03-01)

Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review
by: María Dolores Cima Cabal, et al.
Published: (2023-01-01)

Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review.
by: María Dolores Cima Cabal, et al.
Published: (2023-01-01)

Procoagulant Activity of Blood and Microvesicles Is Disturbed by Pneumococcal Pneumolysin, Which Interacts with Coagulation Factors
by: Sonja Oehmcke-Hecht, et al.
Published: (2022-07-01)

Structural investigations of pneumolysin/lipid complexes and pneumolysin-cholesterol interactions
by: Bonev, B, et al.
Published: (2002)

A 3’UTR-derived small RNA represses pneumolysin synthesis and facilitates pneumococcal brain invasion
by: Kaiqiang Shen, et al.
Published: (2024-09-01)

Detoxified pneumolysin derivative ΔA146Ply inhibits triple- negative breast cancer metastasis mainly via mannose receptor-mediated autophagy inhibition
by: Hong Zhang, et al.
Published: (2024-12-01)

Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival
by: Subramanian, Karthik, et al.
Published: (2021)

Structural investigations of pneumolysin/lipid complexes.
by: Bonev, B, et al.
Published: (2000)

Inhibition of Pneumolysin Cytotoxicity by Hydrolysable Tannins
by: Santeri Maatsola, et al.
Published: (2020-12-01)

Gila-gila PSP /
by: 311618 Maslina Ngadiman
Published: (2010)

Incomplete pneumolysin oligomers form membrane pores.
by: Sonnen, A, et al.
Published: (2014)

The molecolar interaction of pneumolysin with lipid bilayers and cholesterol
by: Boyan, B, et al.
Published: (2000)

Measuring kinetic drivers of pneumolysin pore structure.
by: Gilbert, R, et al.
Published: (2016)

pIgR and PECAM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion
by: Iovino, Federico, et al.
Published: (2017)

Structural basis of pore formation by the bacterial toxin pneumolysin.
by: Tilley, S, et al.
Published: (2005)

Structural basis of pore formation by the bacterial toxin pneumolysin
by: Tilley, S, et al.
Published: (2005)

Psp Green Carnival 2017
by: CETREE, Pusat Pendidikan dan Latihan Tenaga Boleh Baharu, Kecekapan Tenaga dan Teknologi Hijau
Published: (2017)

Meningitis-associated pneumococcal serotype 8, ST 53, strain is hypervirulent in a rat model and has non-haemolytic pneumolysin which can be attenuated by liposomes
by: Annelies Müller, et al.
Published: (2023-01-01)

Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate
by: Luciano Zane, et al.
Published: (2023-01-01)